Your browser doesn't support javascript.
loading
5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort.
Dekalo, Snir; McArthur, Eric; Campbell, Jeffrey; Ordon, Michael; Power, Nicholas; Welk, Blayne.
Affiliation
  • Dekalo S; Division of Urology, Department of Surgery, Western University, London, Ontario, Canada; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: snirdekalo@gmail.com.
  • McArthur E; Institute for Clinical Evaluative Sciences, London, Ontario, Canada.
  • Campbell J; Division of Urology, Department of Surgery, Western University, London, Ontario, Canada.
  • Ordon M; Institute for Clinical Evaluative Sciences, London, Ontario, Canada; Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Power N; Division of Urology, Department of Surgery, Western University, London, Ontario, Canada.
  • Welk B; Division of Urology, Department of Surgery, Western University, London, Ontario, Canada; Institute for Clinical Evaluative Sciences, London, Ontario, Canada.
Urol Oncol ; 41(1): 50.e11-50.e17, 2023 01.
Article in En | MEDLINE | ID: mdl-36319553
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Urinary Bladder Neoplasms Limits: Humans / Male Country/Region as subject: America do norte Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Hyperplasia / Urinary Bladder Neoplasms Limits: Humans / Male Country/Region as subject: America do norte Language: En Journal: Urol Oncol Journal subject: NEOPLASIAS / UROLOGIA Year: 2023 Document type: Article Country of publication: United States